Angiodynamic Inc

NASDAQ:ANGO   4:00:00 PM EDT
12.16
+0.10 (+0.83%)
4:05:10 PM EDT: $12.16 0.00 (0.00%)
Products, Litigation

Jury Enters Verdict That Certain Of Angiodynamics Inc's Implantable Port Products Infringe Certain U.S. Patents Held By BARD

Published: 11/23/2022 21:56 GMT
Angiodynamic Inc (ANGO) - Angiodynamics Inc - on Nov 22, 2022, , Jury Entered Verdict That Certain of Co's Implantable Port Products Infringe Certain U.S. Patents Held by Bard.
Angiodynamics Inc - Issue of Damages Was Bifurcated by Court During Trial, Was Not Determined by Jury and Will Be Subject to a Separate Proceeding.
Angiodynamics Inc - Company Believes It Has Meritorious Defenses, Positions With Respect to the Matters Remaining to Be Decided and the Jury Decision.
Angiodynamics Inc - Intends to Vigorously Pursue All Available Remedies and Defenses, Including Post-trial Motions and Appeals.